Inactive Instrument

Cornerstone Therapeutics, Inc. Stock

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

14-02-28	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
14-02-03	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
14-01-31	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
13-11-20	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
13-10-31	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

13-09-16	USA-Les valeurs à suivre à Wall Street (actualisé)
13-09-16	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	2020-12-31
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.17%	+1.61%	+16.42%	+85.22%	48.73B
OTSUKA HOLDINGS CO., LTD.	+1.04%	-1.02%	+69.47%	+115.88%	35.82B
CIPLA LIMITED	-0.13%	-1.29%	-2.60%	+41.58%	12.2B
ZYDUS LIFESCIENCES LIMITED	-0.71%	+0.89%	+18.28%	+97.87%	12.11B
KRKA, D. D.	-0.76%	+0.38%	+33.16%	+123.08%	9.11B
ONO PHARMACEUTICAL CO., LTD.	-0.86%	+0.37%	+52.61%	-3.54%	7.09B
GEDEON RICHTER	+0.75%	-0.82%	+17.49%	+44.79%	7B
GLENMARK PHARMACEUTICALS LIMITED	+0.69%	+3.25%	+19.90%	+243.91%	6.7B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+5.45%	-7.36%	-17.93%	+13.17%	5.78B
Average	+0.59%	-0.42%	+22.98%	+84.66%	16.06B
Weighted average by Cap.	+0.33%	+0.11%	+29.79%	+90.75%

Employees

Sector